Cargando…
Experimental Modeling of Myeloproliferative Neoplasms
Myeloproliferative neoplasms (MPN) are genetically very complex and heterogeneous diseases in which the acquisition of a somatic driver mutation triggers three main myeloid cytokine receptors, and phenotypically expresses as polycythemia vera (PV), essential thrombocytosis (ET), and primary myelofib...
Autores principales: | Lanikova, Lucie, Babosova, Olga, Prchal, Josef T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826898/ https://www.ncbi.nlm.nih.gov/pubmed/31618985 http://dx.doi.org/10.3390/genes10100813 |
Ejemplares similares
-
Iron chelation and 2‐oxoglutarate‐dependent dioxygenase inhibition suppress mantle cell lymphoma's cyclin D1
por: Babosova, Olga, et al.
Publicado: (2019) -
Presence of Polyclonal Hematopoiesis in Females with Ph-negative Myeloproliferative Neoplasms
por: Swierczek, Sabina, et al.
Publicado: (2015) -
Epigenetics in Myeloproliferative Neoplasms
por: McPherson, Suzanne, et al.
Publicado: (2017) -
Aetiology of Myeloproliferative Neoplasms
por: McMullin, Mary Frances, et al.
Publicado: (2020) -
Targeted therapies for myeloproliferative neoplasms
por: Li, Bing, et al.
Publicado: (2019)